What did @drchloevic actually say?
She's three weeks into compounded tirzepatide, taking "25 units" subcutaneously on shot day, before breakfast, in the morning. Her reported side effects are minimal: "maybe a little bit of mild nausea on the day of the shot," with appetite suppression hitting roughly 24 to 48 hours post-injection. She's down seven pounds and framing this as a straightforward, low-drama start. She also refers to the medication as "compounds in my blue tide," which appears to be a transcription artifact for compounded tirzepatide.
The claims here are experiential rather than medical, which is mostly fine for a personal account. But the "25 units" language creates a real problem for anyone watching and trying to interpret their own prescription, and her framing of side effects as mild and expected deserves some scrutiny against what the literature actually shows.
Does the science back this up?
Her reported timeline for appetite suppression is plausible. Tirzepatide's dual GIP and GLP-1 receptor agonism produces appetite reduction through central and peripheral pathways, and anecdotal onset variation in the first weeks is consistent with the pharmacokinetic profile. The drug has a half-life of roughly five days, so steady-state effects take several weeks to accumulate.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed mean weight loss of 20.9% at 72 weeks with 15 mg tirzepatide. Early weight loss in the first three weeks at lower doses, like the seven pounds she reports, is biologically possible, though some of that is likely water weight and glycogen depletion rather than fat loss, particularly this early. Nausea as the primary early side effect is consistent with the SURMOUNT-1 adverse event profile, where gastrointestinal symptoms were most common during dose escalation.
What did they get wrong (or right)?
The biggest issue is the "25 units" framing. Compounded tirzepatide is typically prepared in a concentration of 5 mg/mL or similar, meaning units are not a universal measure here. Unlike insulin, where units have a standardized meaning, peptide doses measured in units are concentration-dependent. Saying "25 units" without stating the concentration of the vial tells viewers essentially nothing clinically useful, and worse, it could lead someone to assume their prescription works the same way. This is a real harm vector.
She gets credit for not overclaiming. She doesn't say tirzepatide cured anything, she doesn't recommend a dose to viewers, and she openly notes side effects may worsen at higher doses. That kind of epistemic humility is rarer than it should be in GLP-1 content. The morning injection timing before breakfast is not contraindicated, though some clinicians suggest evening dosing to sleep through peak nausea.
What should you actually know?
Compounded tirzepatide is not the same as Mounjaro or Zepbound. The FDA has repeatedly flagged concerns about compounded GLP-1 products, including dosing inconsistencies and sterility questions. In 2024, the FDA issued a statement warning that compounded tirzepatide products lack the clinical trial data that supports the brand-name versions.
The "units" problem is not trivial. A 2023 case series in Obesity Medicine documented dosing errors in patients self-administering compounded peptides partly because of unit-versus-milligram confusion. Anyone on a compounded GLP-1 should confirm their dose in milligrams with the prescribing clinician, not units, and should verify the concentration printed on their vial.
Seven pounds in three weeks sounds exciting, and it may well be real progress. But early rapid weight loss on GLP-1 therapy often includes fluid shifts. The more meaningful number will come at the 12-week mark.
The bottom line
This is a personal progress video, not a medical tutorial, and it should be evaluated as such. The creator's experience is genuine and her side effect report is consistent with the pharmacology. But the unit-based dosing language is genuinely confusing and should not be replicated. If you are on a compounded tirzepatide protocol and your prescription is written in units, call your provider and ask for the milligram equivalent and vial concentration before your next injection.